The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
- Conditions
- CholangiocarcinomaGallbladder CancerPancreas Cancer
- Interventions
- Other: Measurement of triceps skinfold thickness
- Registration Number
- NCT03637569
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
In this study, the investigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.
- Detailed Description
Cachexia is frequently seen in pancreatic cancer(70-80%) and associated with reduced survival, reduced treatment tolerance and reduction in QoL. In recent studies, low-normal BMI have worse outcome (overall mortality) in cardiovascular, malignant, chronic disease (So called "obesity paradox") BMI is simple method but hard to define body composition because BMI is based on only weight and height. Skinfold thickness is strongly associated with body fatness than BMI. In this study, the ivestigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
- Newly diagnosed pancreatic, bile duct or gallbladder cancer patients, undergoing therapeutic management (including surgery, chemotherapy or palliative care).
- Age above 18 years old
- Other malignant disease
- Underlying intestinal disease that cause absorprtion disorder
- Underlying psychiatric disorder such as eating disorder (bulimia, anorexia)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Cancer patients Measurement of triceps skinfold thickness Newly diagnosed pancreatic, bile duct or GB cancer patients at samsung medical center.
- Primary Outcome Measures
Name Time Method Overall survival through study completion, an average of 2 year The duration between diagnosis and death
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of